在基于酸盐的连续脏替代疗法中,电路存活率的进一步改善
Alena Post1, Èmese R H Heijkoop1, Lotte L M Diebels1
1Department of Critical Care, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Clinical kidney journal
|August 5, 2024
概括
使用新方案 (CVVHDF/RCA3.0) 的连续代疗法 (CRRT) 与之前的方法 (CVVH/RCA2.2) 相比,显著改善了电路存活率. 这增强了急性损伤的危急病患者的CRRT输送.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 关键护理医学 关键护理医学
- 重症监护病房的重症监护病房.
背景情况:
- 持续置换疗法 (CRRT) 是急性损伤 (AKI) 在重症监护中的标准.
- 保持电路通透性是CRRT交付中的一个重大挑战.
- 为了解决电路通透性问题,开发了一种新的CRRT协议,即连续静脉静脉血液过与3.0 mmol/l区域酸盐抗凝剂 (CVVHDF/RCA3.0).
研究的目的:
- 为了比较新的CVVHDF/RCA3.0协议的有效性和安全性.
- 为了评估其性能与以前的协议相比,连续静脉静脉血过与2.2区域酸盐抗凝药 (CVVH/RCA2.2).
- 评估对重症性AKI患者CRRT电路存活率和代谢控制的影响.
主要方法:
- 追溯性研究比较了两个CRRT协议:CVVHDF/RCA3.0和CVVH/RCA2.2.
- 纳入标准:在2020年4月至2021年10月期间,患有需要CRRT的AKI的成年重症患者.
- 收集患者人口统计,电路存活率和代谢参数的数据.
主要成果:
- 与CVVHDF/RCA3.0 (39.6小时) 相比,CVVH/RCA2.2 (22.9小时) 的中位数电路存活时间明显更长 (P < .001).
- 较高的体重和对流流量与电路存活率的降低有关.
- 与CVVHDF/RCA3.0 (19%) 相比,与CVVH/RCA2.2 (46%) (P = .006) 相比,代谢性发生的频率较低.
结论:
- 与CVVHDF/RCA2.2协议相比,CVVHDF/RCA3.0协议显示出优越的CRRT电路存活率.
- 优化CRRT协议对于改善AKI患者的治疗治疗至关重要.
- 新的协议还显示了代谢性酶的减少,表明安全性和有效性有所改善.
更多相关视频
09:29Technique of Subnormothermic Ex Vivo Liver Perfusion for the Storage, Assessment, and Repair of Marginal Liver Grafts
Published on: August 13, 2014
15.0K
15:43Assessment of Mitochondrial Functions and Cell Viability in Renal Cells Overexpressing Protein Kinase C Isozymes
Published on: January 7, 2013
18.1K
相关概念视频
01:27Dialysis
281
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
281
01:27Parentral Nutrition: Centeral and Peripheral Parental Nutrition
115
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
115